Evidence map›Paper›PMID 34641334›Full record

ReviewMolecules (Basel, Switzerland)2021

Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review.

Tiantian Tan, Jie Li, Ruhua Luo, Rongrong Wang, Liyan Yin, Mengmeng Liu, Yiying Zeng, Zhaowu Zeng, Tian Xie

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Chinese herbal medicines · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Effects of the Supercritical Fluid Extract ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tiantian TanSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0003-0676-3706
Jie LiSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0002-7163-8242
Ruhua LuoSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0001-5635-2636
Rongrong WangSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0002-7271-6492
Liyan YinSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0003-3759-8571
Mengmeng LiuSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0002-5420-5111
Yiying ZengSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0002-9455-5239
Zhaowu ZengSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0001-6938-555X
Tian XieSchool of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.ORCID 0000-0001-7066-1443
Hangzhou Normal University · CN

Funding

Key Project of Hangzhou Ministry of Science and Technology Grant No.20212013B03Key Project of Zhejiang project Ministry of Science and Technology Grant No.2021C03087National Natural Science Foundation of China Grant No. 81730108Program of Basic Public Welfare Research in Zhejiang Province of China Grant No. LGF20H300006
6 · The paper itself

Abstract

Malignant tumors are life-threatening, and chemotherapy is one of the common treatment methods. However, there are often many factors that contribute to the failure of chemotherapy. The multidrug resistance of cancer cells during chemotherapy has been reported, since tumor cells' sensitivity decreases over time. To overcome these problems, extensive studies have been conducted to reverse drug resistance in tumor cells. Elemene, an extract of the natural drug

Indexed as

Antineoplastic AgentsAutophagyCell Line, TumorCell SurvivalDrug Resistance, NeoplasmDrug SynergismExosomesGene Expression Regulation, NeoplasticHumansNeoplasmsSesquiterpenesAntineoplastic AgentselemeneSesquiterpeneselemenemechanismmultidrug resistancetumor

Identifiers

PMID34641334
PMCPMC8510449
OpenAlexW3202045675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.